Skip to content

Oruka Therapeutics, Inc. ORKA Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$13.63B-7.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$4.82B+17.8%
Amgen logo
AmgenAMGN
$4.11B+26.2%
AbbVie logo
AbbVieABBV
$150M-97.3%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$26.5M+48.9%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$12.01M+38.4%

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.03B+533%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s prepaid & other current?
Oruka Therapeutics, Inc. (ORKA) reported prepaid & other current of $6.42M in Q1 2026.
How has Oruka Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Oruka Therapeutics, Inc.'s prepaid & other current increased by 114.8% year-over-year, from $2.99M to $6.42M.
What is the long-term trend for Oruka Therapeutics, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s prepaid & other current has grown at a 50.0% compound annual growth rate (CAGR), from $897K to $6.81M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.